ANNA CARBÓ BAGUÉ

Oncología de Precisión de Girona

Sánchez Cánovas M, López Robles J, García Verdejo FJ, Cacho Lavin D, Olivares H, Garrido Fernández A, Coma Salvans E, Quintanar Verduguez T, Salvador Coloma C, Fernández Garay D, Cumplido JD, Ferrer Pérez AI, Carbó Bagué A, Teigell Muñoz FJ, García López R, Martínez Marin A, Muñoz Martín AJ

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Clinical & Translational Oncology, 2025 dx.doi.org/10.1007/s12094-025-04048-z

Oncología de Precisión de Girona

Gallego A, Madariaga A, Estévez-García P, Albertí F, Carbó A, Palacio I, Churruca C, Gálvez F, Ortega ME, Murata P, Manzano A, Masvidal M, Martín-Lorente C, Hernando B, Lozano I, Cueva JF, García-Illescas D, Gost E, Mendiola M, Redondo A

An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study).

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2025, 35, 101903-101903 dx.doi.org/10.1016/j.ijgc.2025.101903

Oncología de Precisión de Girona

Rubio, MJ, Manzano, A, de Sande, LM, Estévez-García, P, Gordon, MD, de Prado, DS, de Aranguiz, BHF, Guerra-Alia, EM, Carbó-Bagué, A, Romero, I, Corbellas, M, González-Haba, A, Robles-Barraza, CE, Martínez-García, J, González-Martín, A

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

BMC CANCER, 2024, 24 dx.doi.org/10.1186/s12885-024-12577-z

Oncología de Precisión de Girona

Plaja A, Teruel I, Ochoa-de-Olza M, Cucurull M, Arroyo ÁJ, Pardo B, Ortiz I, Gil-Martin M, Piulats JM, Pla H, Fina C, Carbó A, Barretina-Ginesta MP, Martínez-Román S, Carballas E, González A, Esteve A, Romeo M

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms241411420

Oncología de Precisión de Girona

Pla-Juher H, Pardo M, Izquierdo ÀJ, Darder E, Carbó A, Munté E, Torres-Esquius S, Balmaña J, Lázaro C, Brunet JM, Barretina-Ginesta MP

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.

Clinical & Translational Oncology, 2023, 26, 1033-1037 dx.doi.org/10.1007/s12094-023-03312-4

Oncología de Precisión de Girona

Carbó-Bagué A, Cerón-Nasarre L, Valls-Masot L, Melendez-Munoz C, Bujons-Buscarons E, Liñan-Planas R, Barretina-Ginesta MP

Esophageal Infiltration by High-Grade Serous Ovarian Carcinoma: A Very Rare Case Report.

Case Reports in Oncology, 2023, 16, 1436-1442 dx.doi.org/10.1159/000534702

Epidemiología descriptiva, genética y prevención del cáncer , Genética Cardiovascular , Oncología de Precisión de Girona

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780

Epidemiología descriptiva, genética y prevención del cáncer , Hematología , Oncología de Precisión de Girona

Rubió-Casadevall J, Carbó-Bagué A, Puigdemont M, Osca-Gelis G, Oliveras G, Vilar-Coromina N, Ferrer-Fabrega B, Urban A, Llobet-Roma M, Martín-Romero F, Perez-Bueno F, Marcos-Gragera R

Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor

EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31, 616-622 dx.doi.org/10.1684/ejd.2021.4136

Epidemiología descriptiva, genética y prevención del cáncer , Oncología de Precisión de Girona

Carbó-Bagué A, Fort-Culillas R, Pla-Juher H, Rubió-Casadevall J

Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report

Case Reports in Oncology, 2021, 14, 1289-1294 dx.doi.org/10.1159/000518530

Epidemiología descriptiva, genética y prevención del cáncer , Oncología de Precisión de Girona

Soosaipillai G, Wu A, Dettorre GM, Diamantis N, Chester J, Moss C, Aguilar-Company J, Bower M, Sng CC, Salazar R, Brunet J, Jones E, Mesia R, Jackson A, Mukherjee U, Sita-Lumsden A, Seguí E, Ottaviani D, Carbó A, Benafif S, Würstlein R, Carmona C, Chopra N, Cruz CA, Swallow J, Saoudi N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Wong YNS, Sureda A, Maluquer C, Ruiz-Camps I, Cabirta A, Prat A, Loizidou A, Gennari A, Ferrante D, Tabernero J, Russell B, Van Hemelrijck M, Dolly S, Hulbert-Williams NJ, Pinato DJ

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13 dx.doi.org/10.1177/17588359211042224

Directori

Publicacions

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study).

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.

Esophageal Infiltration by High-Grade Serous Ovarian Carcinoma: A Very Rare Case Report.

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor

Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

Formulari de contacte

Conoce el IDIBGI!